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1. Introduction 
Spinocerebellar ataxias (SCAs) are a heterogeneous group of autosomal dominant 
neurodegenerative disorders characterized by a progressive cerebellar syndrome, variably 
associated to signs of brainstem involvement, pyramidal or extrapyramidal manifestations 
and cognitive dysfunctions, among other features that confer a remarkable wide range in 
phenotypes (Harding, 1983; Durr, 2010). 
SCAs are associated with at least 31 different genetic loci, but the responsible gene is known 
in only 19 of them. Causative mutations include coding CAG expansions leading to a long 
polyglutamine (polyQ) tract in the respective proteins (SCA1, 2, 3, 6, 7 and 17), non-coding 
trinucleotide or pentanucleotide expansions (SCA8, 10, 12 and 31), as well as conventional 
mutations (SCA5, 11, 13, 14, 15/16, 20, 27 and 28) (Durr, 2010). The worldwide prevalence of 
SCAs is estimated near to 5-7 cases per 100 000 inhabitants but it can be higher in some 
regions due to foundational effects such as SCA2 in Holguín, Cuba (Velazquez-Pérez et al., 
2009a)  and  SCA3 in Azores islands, Portugal (Vale et al., 2010). 
Oculomotor disturbances are prominent features of SCA patients as result of cerebellar and 
brainstem neurodegeneration (Zee et al., 1976; Pula et al., 2010). The study of eye movement 
abnormalities give us valuable tools to search disease biomarkers because they can be easily 
accessible to clinical and/or electrophysiological evaluations and their dynamic properties 
and neurobiological basis are well known (Leigh & Kennard, 2004; Leigh & Zee, 2006; Reilly 
et al., 2008). The focus of this chapter is to review the state of the art of the eye movement 
deficits in SCAs, emphasizing in the usefulness of these features as disease biomarkers. 
2. Brief overview of eye movements 
Eye movements contribute to the clear vision stabilizing images on the retina, especially 
against movements of the head and body, capturing and keeping particular stimuli on the 
fovea and aligning the retinal images in the two eyes to guarantee the single vision and 
stereopsis. These functions can be achieved by 5 basic types of eye movements. For example, 
the image stabilization on the retina is promoted by the vestibulocular and optokinetic 
reflexes; the foveation occurs thorough the saccadic and smooth pursuit movements, 
whereas the binocular alignment is guaranteed by the vergence eye movements (Bruce & 
Friedman, 2002).  
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Eye movements differ in many aspects, such as their velocity, reaction time, 
reflexivity/volitional degree and their neurobiological substrate (Sparks, 2002). 
Nevertheless all have generic kinematic properties and share a common final path 
represented by three cranial nerve nuclei and the three pairs of eye muscles that they control 
(Bruce & Friedman, 2002; Leigh & Zee, 2006). Cranial nerve III (oculomotor) innervates 
superior, inferior and medial rectus muscles as well as the inferior oblique muscle, whereas 
troclear (IV) and abducens (VI) nerves innervate the superior oblique and lateral rectus 
respectively (Leigh & Zee, 2006).  
Main features and neurophysiological bases of the 5 basic types of eye movements will be 
briefly addressed as follow.  
2.1 Vestibulocular reflex (VOR) 
The vestibulocular reflex (VOR) is elicited by the vestibular system in response to 
body/head rotations and consists in compensatory eye movements in opposite direction to 
body/head movement to guarantee the image stabilization on the retina (Aw et al., 1996). 
VOR depends of two neural circuits: a) Basic three neurons circuit and, b) Neural integrator 
circuit.  
In the basic three neurons circuit, the head/body rotations are detected and transduced by 
vestibular ganglion neurons in the semicircular canal. Then, the transduced information is 
projected to neurons of the vestibular nuclei, located in the pons, and from there to 
oculomotor neurons (OMN) in one of the three oculomotor nuclei. Nevertheless, the three 
neurons circuit by itself is unable to adequately stabilize the image on the retina because it 
only generates phasic innervations of the oculomotor muscles, causing the return of the eye 
back to the central position due to the pulling of elastic forces.  The neural integrator serves 
to exactly overcome this elastic force producing tonic innervations of oculomotor muscles. It 
is located in the prepositus hypoglossi and medial vestibular nuclei, which receive projections 
from the vestibular nuclei and have recurrent connections onto themselves. Some vestibular 
afferents go directly to the floculus/parafloculus cerebellar lobe, which is involved in VOR 
adaptation (Bruce & Friedman, 2002). 
2.2 Optokinetic reflex (OKR)  
When head/body rotations are very large and continued the VOR is depressed and thus it is 
complemented by the optokinetic reflex (OKR), in which the speed and direction of a full-
field image motion is computed to develop eye movements with two phases, an slow phase 
that  alternates with resetting quick phase (Tusa & Zee, 1989).  Pathway underlying OKR 
includes the nucleus of the optic tract, which receives visual motion signals from the 
contralateral eye and striate/extrastriate cortical areas. This information is send to the 
vestibular nuclei and to the inferior olivary nucleus, and then to the flocular/paraflocular 
Purkinje cells via their climbing fibers (Bruce & Friedman, 2002). 
2.3 Saccadic eye movements 
Saccades are ballistic, conjugate eye movements that redirect fovea from one object of 
interest to another, allowing to explore accurately the visual scenes. For that, the saccadic 
system processes information about the distance and direction of a target image from the 
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current position of gaze. Saccades are the fastest eye movements, reaching up to 6000/s. 
There are close relationships between saccadic peak velocities, durations and amplitudes, 
which represent the saccadic main sequence (Bahill et al., 1975, Ramat et al., 2007).  
Behaviourally, the saccades may be classified as reflexive guided saccades and intentional or 
volitional saccades. The first ones are evoked by the suddenly appearing targets, whereas 
the second ones, called also higher-order saccades, are made purposely, involve high 
cognitive processing and include voluntary, memory guided and delayed saccades as well 
as antisaccades (Müri & Nyffeler, 2008; Leigh & Kennard, 2004).   
The neural basis of saccadic eye movements system comprises some cortico-cortical and 
cortico-subcortical networks (Müri & Nyffeler, 2008). Visual information processed in the 
primary visual cortex is send to higher cortical areas, such as parietal eye field (PEF) and 
frontal eye field (FEF), which are involved in the preparation and triggering of reflexive and 
intentional saccades respectively (Pierrot-Deseilligny, et al., 2004). These cortical areas 
project their output directly or through the basal ganglia, to superior colliculus, a midbrain 
structure that identifies the target in retinotopic coordinates, generates trigger signal to the 
brainstem premotor oculomotor circuitry and encodes the magnitude and direction of the 
desired eye movement. This information is projected to the cerebellum, via a pontine pre-
cerebellar nucleus, which guarantees the saccadic accuracy. Premotor burst neurons (PBN)  
for horizontal saccades  lie within  the paramedian pontine reticular  formation  (PPRF)  
while burst neurons  for vertical  and  torsional  saccades  lie  within  the  rostral  interstitial  
nucleus  of  the  medial longitudinal fasciculus. Saccade-related cerebellar areas include the 
oculomotor vermis (lobules VI and VII) and the caudal region of the fastigial nucleus which 
send saccade commands to the contralateral PBNs leading the activation of motorneurons 
and oculomotor muscles related with the desired saccadic movement (Leigh & Zee, 2006; 
Robinson  & Fuchs, 2001;  Prsa & Their, 2011; Voogd et al., 2011).  
2.4 Smooth pursuit movements 
Smooth-pursuit eye movements enable us to maintain the image of a moving object 
relatively stable on or near the fovea by matching eye velocity to target velocity (Leigh & 
Zee, 2006). Smooth pursuit performance is optimal for target speeds ranging between 150/s 
and 300/s but pursuit velocity can reach up to 1000/s (Lencer & Trillenberg 2008; Bruce & 
Friedman, 2002). Smooth pursuit system is closely related to other oculomotor systems such 
as OKR and saccadic system. In fact, the small position errors raised when the tracking 
velocity is not properly matched to the target are corrected by saccadic movements named 
“catch up” saccades (Lencer & Trillenberg, 2007). 
Neuronal pathways for smooth pursuit movements involve a complex network of cortical 
and subcortical structures. Extrastriate visual area V5 (divided into middle temporal visual 
area (MT) and the medial superior temporal visual area (MST)) play a crucial role for motion 
perception and smooth pursuit control.  This area receives visual motion information from 
the primary visual cortex in a retinotopic and ipsilaterally organized fashion. The MT area 
encodes image motion in a retinal coordinate system whereas MST area converts the signals 
into a spatial coordinate system. The signals generated in the V5 area are projected to other 
cortical areas in the parietal and frontal lobes. Among them, the frontal eye field (FEF) is 
involved in the generation of oculomotor command for smooth pursuit. Both visual motion 
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signals and oculomotor commands are relayed to oculomotor parts of the cerebellum, 
through the dorsolateral and medial pontine nuclei. Smooth pursuit-related areas of the 
cerebellum comprise the paraflocculus, the flocculus, the oculomotor vermis and the uvula, 
which control the initiation and maintenance of smooth pursuit. Finally, the cerebellar 
output is projected, via the vestibular nuclei, to the oculomotor nuclei (Lencer & Trillenberg, 
2007; Mustari et al., 2009). 
2.5 Vergence eye movements 
Vergence eye movements are disjunctive movements that provide the binocular alignment 
in response to changing fixation target distances, requiring that both eyes point in contrary 
directions (Zee & Levi, 1989). Vergence movements are elicited by retinal disparity (when a 
fixation target is not on both foveae) and retinal blur (when a target is not in focus) and are 
closely related to the lens accommodation and pupillary reflexes. Although the neural basis 
of vergence eye movements are not well understood, it is known that both the retinal 
disparity and the retinal blur signals are processed by cortical visual areas such as primary 
visual cortex (V1) and an anterior region of the FEF. Additionally, it is presumed an 
important role of the oculomotor nucleus (III) for vergence movements, due to its known 
relation to lens accommodation and pupillary reflexes (Vilis, 1997; Bruce & Friedman, 2002). 
The cerebellum is involved in the processing of dynamic vergence eye movements (Sander 
et al., 2009). Cerebellar regions related with these disconjugate eye movements lie on the 
dorsal paraflocculus, and the floccular lobe, which project to the lateral portion of the 
posterior interposed nucleus (Voogd et al., 2011). 
2.6 Oculomotor disturbances  
Oculomotor disturbances can be topographically classified as peripheral or central 
disturbances. Peripheral abnormalities result from lesions in the oculomotor muscles or 
nerves, whereas the central disturbances are caused by lesions in the brainstem, cerebellum 
or other higher-level centers (Karatas, 2009). Oculomotor signs of cerebellar impairment 
include pathological nystagmus such as downbeat, rebound and periodic alternating 
nystagmus, as well as abnormal pursuit, VOR/OKR abnormalities and saccadic dysmetria 
(Robinson & Fuchs, 2001; Strupp et al., 2011). Whereas, brainstem involvement produces 
slowed vertical, torsional or horizontal saccades, ophthalmoplegia, VOR/OKR impairments 
and gaze-evoked nystagmus (Rüb et al., 2008, Strupp et al., 2011). Affectations in the basal 
ganglia can lead to reduced ability to initiate voluntary eye movements and to suppress 
unwanted saccades, in addition to deficits in memory-guided saccades, eye-head 
coordination and eye-hand coordination (Hikosaka et al., 2000; Shires et al., 2010). Frontal 
cortex lesions produce prolongation of saccadic latency, impaired ability to make saccades 
to remembered target locations and errors on the antisaccade task, as well as delayed 
initiation of smooth pursuit and increase of catch up saccades (Pierrot-Deseilligny et al., 
2004; Thurtell et al., 2007; Karatas, 2009).  
3. Oculomotor findings of spinocerebellar ataxias  
3.1 Spinocerebellar ataxia type 1 (SCA1) 
The main eye movement abnormalities of SCA1 patients include saccadic dysmetria, gaze 
evoked nystagmus and depressed smooth pursuit (Matilla-Dueñas et al., 2008). Saccadic 
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hypermetria is observed in majority of the cases, appears at an early stage of the disease and 
progresses quickly (Klostermann et al., 1997; Rivaud-Pechoux et al., 1998; Buttner et al., 
1998). The overshoot of saccades may reach values greater than 30% in comparison with 
normal subjects (Buttner et al., 1998).  
Brainstem oculomotor signs such as saccadic slowing or ophthalmoparesis are observed in 
74% (Schmitz-Hübsch, et al., 2008). Reduction of saccade velocity can be detected in mildly 
affected patients and it is accentuated with the disease duration. Advanced patients may 
show ophthalmoparesis or severe saccadic slowing, so that saccadic hypermetria is less 
noticeable in comparison to early stages (Klostermann et al., 1997). Abnormal prolongation 
of saccadic latency occurs in 67% of cases (Buttner et al., 1998), whereas the execution of the 
antisaccadic task shows increased error rates, suggesting the presence of neurodegenerative 
changes in the frontal cortex (Rivaud-Pechoux et al., 1998).    
Reduced gain of smooth pursuit and OKN is noticed in 92% of SCA1 cases  with the lowest 
smooth pursuit gains in comparison to SCA2 and SCA3 patients and comparable values of 
OKN gains to SCA2 (Burk et al., 1998). The progressive saccadic slowing causes the 
diminution of catch up saccades during visual tracking, leading to decrease of the smooth 
pursuit amplitudes on advanced disease (Buttner et al., 1998, Klostermann et al., 1997). 
Regarding vestibular functions, SCA1 patients are usually characterized by reduced VOR 
gains, which distinguish this SCA subtype from SCA2 but neither from SCA3 nor SCA6 
(Burk et al., 1998; Buttner et al., 1998).  
No oculomotor abnormalities of SCA1 patients correlate with the number of CAG repeats 
(Burk et al., 1999; Rivaud-Pechoux et al.,1998), suggesting that they are not under significant 
genetic control but are more dependent on disease duration.  
3.2 Spinocerebellar ataxia type 2 (SCA2) 
The most common oculomotor sign in patients with SCA2 is a significant reduction in 
horizontal saccadic eye velocity owing to brainstem involvement. This feature called 
attention to Wadia and Swami when made the first report of SCA2 in 1971, so that they 
described the disease as “a new form of heredofamilial spinocerebellar degeneration with slow eye 
movements” (Wadia & Swami, 1971). Several clinical and epidemiological studies have 
confirmed the high frequency of this saccadic alteration in more than 80% of cases 
(Velazquez-Pérez et al., 2009a; Orozco et al., 1989; Cancel et al., 1997, Wadia et al., 1998; 
Schmitz-Hübsch, et al., 2008).  
The first electronystagmographical evaluation of SCA2 patients was conducted by Kulkarni 
& Wadia in 1975 who found a relative decrease of saccadic velocity up to 25% in comparison 
with controls (Kulkarni & Wadia, 1975). Furthermore, comparative studies of oculomotor 
phenotypes among patients with cerebellar ataxias demonstrated that saccadic slowing is 
more prominent in SCA2 patients in comparison with SCA1, SCA3, SCA6 (Burk, et al; 1999; 
Buttner et al., 1998; Rivaud-Pechoux et al., 1998) and late onset cerebellar ataxia (Rufa & 
Federighi, 2011) giving an important diagnostic value to this oculomotor feature for SCA2. 
A comprehensive electronystagmographical study developed in 82 SCA2 Cuban patients 
showed little overlap between maximal saccadic velocity (MSV) values of SCA2 patients and 
controls. This study demonstrated a high sensitivity for SCA2 diagnosis assessed by a 
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receiver operating characteristic (ROC) yielding an area under the curve of 0.99. The most 
important finding of this work was the significant influence of the number of CAG repeats, 
but not of disease duration, on saccadic velocity (Figure 1). According to this relationship, 
patients with larger expansions showed more saccadic slowing, identifying the saccadic 
velocity as the main variable endophenotype of the SCA2, which is under strong genetic 
control and therefore it may be considered as a sensitive biomarker for the study of 
polyglutamine toxicity. Also, MSV was negatively correlated with the total score of a 
cerebellar ataxia scale suggesting its association with the severity of the cerebellar syndrome 
(Velázquez et al., 2004). Other study performed in Cuban SCA2 patients revealed a closer 
relationship between the saccadic velocity and the visuomotor learning capabilities assessed 
by a prism adaptation task (Fernandez-Ruiz, et al., 2007). 
A preliminary follow-up evaluation of saccadic slowing after one year in 30 SCA2 patients 
revealed no significant changes of MSV (Seifried et al., 2004). Nevertheless, other follow-up 
study during a larger period time it is being conducted in a large Cuban SCA2 cohort.   
The saccadic slowing appears during the presymptomatic stage of the disease only for 60° 
target amplitude, but asymptomatic subjects carrying full-penetrant CAG expansions (≥36) 
show reduced MSV values even for 30°. In fact, the MSV reduction is stronger in carriers of 
large expansions. This preclinical feature progresses insidiously and it correlates with 
predicted time to clinical manifestation, which classifies this variable as a preclinical 
biomarker of high values for diagnosis and prognosis of the disease (Velázquez-Pérez et al., 
2009b).  
The neuroanatomical basis of this disorder has been elucidated by post-mortem studies that 
demonstrated the marked loss of excitatory PBN in the PPRF (Buttner-Ennever, et al., 1985; 
Geiner et al., 2008), the structure that coordinates the horizontal saccades (Leigh & Zee, 
2006).  Early, Gierga et al, 2005 had reported a significant neuronal death in the abducens 
(cranial nerve VI) and oculomotor nucleus (cranial nerve III), which innervate the 
oculomotor muscles responsible for eye movements in the horizontal plane (Leigh & Zee, 
2006). 
Hypometric saccades to extreme gaze positions are usual in SCA2 patients (Velázquez, 
2008), nevertheless for short target amplitudes the saccade accuracy is maintained, although 
some patients can make hypermetric saccades. It has been suggested that as SCA2 patients 
having slow saccades that are no longer ballistic, visual feedback might be continuously 
available during the movement execution to guide the eye to its target rendering accurate 
short saccades (Federighi et al., 2011). 
A recent electronystagmographical study in 110 SCA2 patients demonstrated the significant 
prolongation of saccadic latency in 46% of SCA2 patients. This variable was neither 
influenced by the CAG repeats, disease duration nor ataxia score, but it was close related 
with the neuropsychological performance of frontal-executive tasks, which highlights the 
saccadic latency  as sensitive biomarker of cognitive disorders in SCA2 (Rodríguez-Labrada, 
et al., 2011a). Additionally, SCA2 patients show increased antisaccadic error rate (Rivaud-
Pechoux et al., 1998).  The delayed saccade onset and antisaccadic deficits could be 
explained by the severe gyral atrophy and neuronal loss in the frontal lobes and 
neurodegenerative changes in caudate nucleus and substantia nigra (Orozco et al., 1989; 
Durr et al., 1995; Estrada et al., 1999; Gierga et al., 2005), as well as deficits in the processing  
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Fig. 1. Saccadic slowing in SCA2. A) Relationship of saccadic velocity and amplitudes in 
SCA2 patients. Show the significant reduction of saccadic velocity in almost all subjects. 
Dark lines represent the saccadic velocity ± 2 SD of controls. B) Influence of CAG repeat size 
on the saccadic velocity. 
of visual information (Kremlacek et al., 2011) or in the visual-spatial attention (Le Pira et al., 
2002).  
 
            (A)              (B) 
Fig. 2. Saccadic latency correlates with frontal-executive dysfunctions in SCA2 patients. 
Correlation analyses of saccadic latency with achieved categories in the Wisconsin sort card 
test (WSCT) and the number of correct responses in the phonemic verbal test.  
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Other oculomotor alterations include ofthalmoplegia, which usually appears at advanced 
disease in the 45% of the cases, although the severe saccadic slowing might overlook the 
frequency of ofthalmoplegia in SCA2. These patients have mild reduction of smooth pursuit 
gain in correspondence with the atrophy of cerebellar floculus (Ying et al., 2006) and the 
decrease of catch up saccades. The physiological and pathological nystagmus are very rare 
in SCA2 due to impaired ability to produce saccadic corrective phases. Some SCA2 patients 
have VOR responses with reduced gain (Burk et al., 1999; Rivaud-Pechoux et al., 1998; 
Buttner et al., 1998).  
Saccadic eye movements have also been used to evaluate the efficacy of therapeutical 
alternatives in Cuban SCA2 patients, such as neurorehabilitation (Rodríguez et al., 2008) and 
oral supplementation with zinc-sulphate (Velázquez-Pérez et al, 2011a). In both cases the 
saccadic latency decreased significantly after the therapies, but saccadic velocity and 
dysmetria were unchanged.  
For SCA2, the oculomotor function has not only evaluated in wake state, since the density of 
rapid eye movements (saccadic) during REM sleep was recently assessed. Both symptomatic 
and presymptomatic subjects show a marked decrease in this parameter, which is negatively 
correlated with the ataxia score in the patients (Velázquez-Pérez, et al., 2011b; Rodríguez-
Labrada et al., 2011b). These findings suggest the usefulness of saccadic density during REM 
sleep as progression marker of the disease and reflect the extension of the oculomotor 
brainstem involvement to the sleep.  
3.3 Spinocerebellar ataxia type 3 (SCA3) 
Pathological nystagmus are prominent oculomotor signs of SCA3 patients. The frequency of 
gaze evoked and rebound nystagmus is approximately 90% (Jardim et al., 2001) being 
higher than those in SCA1, SCA2 and SCA6. Square wave jerks are usually reported in 
SCA3 subjects, unlike SCA1 and SCA2 individuals (Buttner et al, 1998; Burk et al., 1998). 
This oculomotor sign results from cerebellar disease and consists in small, horizontal, 
saccade-like movements that lead the eye away from the target trajectory and, after a delay, 
bring it back onto the target (Leigh & Zee, 2006).  
Decreased VOR gain can be detected in majority of SCA3 patients and correlates with the 
CAG repeats, suggesting the pathologic involvement of the vestibular nuclei in the lateral 
brainstem. Furthermore, these patients show reduction of smooth pursuit and OKR gains 
with a presentation frequency above 70% in both cases (Buttner et al, 1998; Burk et al., 1998).  
Upon saccades, the main abnormality is saccadic dysmetria. Nevertheless, there are 
apparently conflicting data regarding the predominant type of dysmetria. Buttner et al., 
1998 reported hypermetric saccades in 86% of the cases, while Rivauld-Pechoux et al., 1998, 
observed a predominance of hypometric (56%) over hypermetric saccades (18%). The 
disagreement can be explained by differences in the clinical stage of studied patients. In fact, 
the 81% of the patients recruited by Rivauld-Pechoux and colleagues had a moderate to 
severe motor disability, which could explain the higher prevalence of saccadic hypometria. 
Different to SCA2 and SCA1, decreased saccadic velocity is not a common feature of SCA3 
patients (Burk et al., 1999; Rivaud-Pechoux et al., 1998; Buttner et al., 1998). This oculomotor 
feature appears in advanced disease, perhaps in correspondence with the degenerative 
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changes seen in the raphe interpositus nucleus (Rub et al., 2003), a key structure of the 
brainstem premotor network that contains the omnipausas neurons, a group of cells that 
play an important role in determining the size of the velocity command for saccades, beside 
their well-known role as gating saccades (Miura & Optican, 2006). Also, internuclear and 
nuclear ophthalmoplegia is observed in 53% and 10% of the cases respectively.  The latter is 
associated with a more severe disease course (Jardim et al., 2001). 
Finally, the prolongation of saccadic latency occurs late in few cases (14%) (Buttner et al., 
1998) and the performance in the antisaccadic paradigm shows an increase in the number of 
errors (Rivaud-Pechoux et al., 1998).   
3.4 Spinocerebellar ataxia type 6 (SCA6) 
Oculomotor function of SCA6 patients is characterized by signs of cerebellar and vestibular 
impairments such as horizontal and vertical nystagmus, abnormal smooth pursuit, saccadic 
dysmetria and abnormal VOR (Buttner et al., 1998; Christova et al., 2008; Bour et al., 2008). 
In comparison with other SCAs, the spontaneous downbeat nystagmus and square-wave 
jerks have the higher incidence in SCA6 subjects, whereas  gaze-evoked nystagmus, 
rebound nystagmus and periodic alternating nystagmus are common features too (Buttner 
et al., 1998; Colen et al., 2008; Kim et al., 2010).  
Patients with SCA6 have the more severe pursuit, OKN and VOR-fixed deficits among other 
polyglutamine SCAs but these oculomotor signs are not directly associated to CAG repeats 
or disease duration (Buttner et al., 1998). Vertical pursuit is impaired more than horizontal 
whereas downward pursuit more than upward (Bour et al., 2008).  
The pattern of saccadic dysmetria in SCA6 is variable since these patients can show both 
hypometric and hypermetric saccades (Buttner et al., 1998; Bour et al., 2008). Although the 
decrease of saccadic velocity is not a prominent sign in these patients, it has been reported a 
mild saccadic slowing in some subjects both for the horizontal and vertical planes (Bour et 
al., 2008). These findings suggest functional extracerebellar impairment in the saccadic 
system and therefore are opposed to the paradigm of SCA6 as a "pure cerebellar syndrome." 
In fact, the screening of non-ataxia signs reveals a 25% of brainstem oculomotor signs 
(Schmitz-Hübsch, et al., 2008). In these patients the saccadic latency is normal (Buttner et al., 
1998).  
In 2009, Christova and co-workers studied the eye movement’s abnormalities in both 
symptomatic and asymptomatic SCA6 cohorts and noticed that square-wave jerks, saccadic 
abnormalities and depressed smooth pursuit can be detected even before the disease onset. 
Among them, the square-wave jerks were the most prominent with an apparition frequency 
of 80% (Christova et al., 2008).  
3.5 Spinocerebellar ataxia type 7 (SCA7) 
The major saccadic alteration in this SCA is the slowing of saccades, together with saccadic 
dysmetria (Miller et al., 2009; Manrique et al., 2009). The decrease in saccadic velocity in 
SCA7 is associated with marked pontine atrophy that characterizes these patients from early 
stages of the disease and progresses to produce significant external ophthalmoplegia in 
patients with longer disease history (Bang et al., 2004; Martin et al., 1999).  These alterations 
www.intechopen.com
 
Spinocerebellar Ataxia 
 
68
may precede cerebellar and retinal manifestations and are among the earliest signs of the 
disease (Oh et al., 2001). In addition, some cases have difficulties to initiate the saccadic eye 
movements and may develop gaze evoked nystagmus (Miller et al., 2009; Manrique et al., 
2009).  
3.6 Spinocerebellar ataxia type 17 (SCA17) 
The patients with SCA17 show hypometric saccades in correspondence with the marked 
reduction of Purkinje cells in the cerebellum (Hubner et al., 2007). The saccadic hypometria 
is increased with disease duration but neither with ataxia score nor the number of CAG 
repeats. In 26% of cases, there are transient saccadic decelerations and accelerations causing 
hypometric saccades with multiple steps. Clinical assessments have reported normal 
(Nakamura, 2001) or slowed saccades (Rolfs et al., 2003), although the hypometria or 
prematurely terminated saccades may conduce to the erroneous classification of slowed 
saccades. In these patients, the saccadic latency is normal, while antisaccades have a 
significant increase in the error rate (Hubner et al., 2007). 
Smooth pursuit abnormalities in SCA17 patients include decrease of initial eye acceleration, 
which appears even in the asymptomatic and mildly affected SCA17 mutation carriers, 
reduced steady state velocity and prolongation of smooth pursuit latency. Smooth pursuit 
gain decreases with the disease duration and ataxia score, whereas the latency prolongation 
correlates positively with the ataxia score. Gaze-evoked nystagmus is not a prominent 
feature in SCA17 patients (Hubner et al., 2007). 
3.7 Other spinocerebellar ataxias 
With the exception of polyglutamine expansions SCAs, the oculomotor function of 
remaining SCAs has not been systematically studied while most of data result for clinical 
assessment.  SCA5 is characterized by eye abnormalities owing to cerebellar impairments 
such as downbeat nystagmus and impaired smooth pursuit movements (Ranum et al., 1994; 
Ikeda et al., 2002). Similar features occur in SCA8, in addition to saccadic dysmetria (Day et 
al., 2000; Koob et al., 1999), and SCA10 (Zu et al., 2000; Grewal et al., 2002; Lin & Ashizawa, 
2005). SCA11 is associated with horizontal and vertical nystagmus as well as jerky pursuit 
(Worth et al., 1999), while approximately one third of SCA12 patients can develop saccadic 
slowing, abnormal smooth pursuits or pathological nystagmus (Worth et al., 1999, 
Fujigasaki et al., 2001). Besides, in subjects affected with SCA13 is usual to observe 
horizontal nystagmus (Stevanin et al., 2005; Waters & Pulst, 2008). 
Regarding SCA14, the main oculomotor disturbance is the hypermetria of downgaze and 
horizontal saccades, even from the early stages of the disease. Additionally, upwards gaze 
evoked nystagmus are common in patients with longer disease duration.  Smooth pursuit 
movements and VOR are also impaired (Yamashita et al, 2000; Brkanac et al, 2002a; Fahey et 
al., 2005). Eye movement abnormalities of SCA15/16 and SCA18 include nystagmus for all 
these SCA subtypes associated to saccadic dysmetria in the first one (Miyoshi et al., 2001; 
Brkanac et al, 2002b; Gardner et al., 2005). In addition, hypermetric saccades into downgaze 
and lateral gaze are detected in some patients with SCA20 (Knight et al., 2004). 
SCA22 patients show nystagmus and impaired smooth pursuit with intermittent corrective 
saccadic (Chung et al., 2003), while in SCA23 the ocular dysmetria and slowed saccades can 
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be noted (Verbeek et al., 2004; Verbeek, 2009).  SCA25, SCA26 and SCA27 are characterized 
by pathological nystagmus in some patients, associated with slow eye movements in SCA25, 
abnormal pursuit in SCA26 and saccadic dysmetria in SCA27 (van Swieten, et al., 2003; 
Stevanin et al. 2004; Yu et al., 2005). SCA28 patients develop gaze-evoked nystagmus at 
early disease, while subjects with advanced disease have slowed saccades and 
ophthalmoparesis with frequency estimates of 60% and 80% respectively (Cagnoli et al., 
2006). SCA29, which overlap with SCA15, is characterized by bilateral horizontal nystagmus 
(Dudding et al., 2004). In the case of SCA30, hypermetric saccades and gaze evoked 
nystagmus can be detected (Storey et al., 2009), as well as abnormal pursuit in SCA31   
(Ishikawa et al., 2004). Finally, in a new SCA subtype recently identified by Wang et al., 2010 
in two Chinese families, it was observed ocular dysmetria as main oculomotor sign.  
4. Conclusions  
Eye movement abnormalities are among the most common phenotypic manifestations of 
patients with SCAs.  The most prominent oculomotor feature is the presence of pathological 
nystagmus in almost all subtypes, which is generally associated to abnormal smooth 
pursuit, saccadic dysmetria, impaired VOR/OKR, saccadic slowing and ophthalmoplegia. 
These oculomotor phenotypes are useful, but not determinant, for the differential diagnosis 
of SCAs. For example, the early and severe saccadic slowing with rare pathological 
nystagmus distinguishes SCA2 from SCA1, SCA3, SCA6, SCA17 and other SCA subtypes, 
whereas the marked abnormalities of smooth pursuit, VOR and OKR; in association with 
pathological nystagmus and rare saccadic slowing may help to define a SCA6 phenotype. 
Nevertheless, the notable overlapping of oculomotor features between SCA subtypes 
implies the requirement of other clinical criteria or the genetic testing for sensitively 
discriminating among these diseases.     
The study of eye movement abnormalities allows the identification of several biomarkers 
useful in the clinical and research practice of SCAs. Some of the oculomotor disturbances 
precede the ataxia onset, being important preclinical markers to detect the early stages of the 
neurodegenerative process, to evaluate the genetic susceptibility of the asymptomatic 
relatives and to identify individuals close to ataxia onset for enrollment in preventive 
clinical trials and as potential outcome variables in these same trials. As most of the 
oculomotor abnormalities of SCAs are significantly accentuated with the advance of the 
disease, these can be used in monitoring clinical progression and therefore to assess the 
response to symptomatic treatments at short, medium or long term. The number of CAG 
repeats influences significantly on the saccadic slowing in SCA2 and the reduced VOR gain 
in SCA3 classifying these oculomotor features as sensitive biomarker of genetic damage, 
useful to evaluate the effect of modifying factors and therapeutic alternatives on the 
polyglutamine toxicity.  
Despite the above, still is necessary to deep more into the study of oculomotor function in 
SCAs. For example, vergence movements have not been studied, in spite of the known 
role of the cerebellum in these eye movements (Robinson & Fuchs, 2001) and the 
correspondent vergence deficits in patients with circumscribed cerebellar lesions (Sender 
et al., 2009). Moreover, further neuropathological, imaging and transcranial magnetic 
stimulation studies are required to focus the oculomotor system in order to provide more 
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insight on eye movement abnormalities and its potential role as therapeutic biomarkers in 
SCAs.  
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